Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Eli Lillys injectable drug retatrutide targets GLP-1, GIP and glucagon receptors
Patients should discuss with their healthcare provider how retatrutide fits into their overall treatment plan, taking into account their medical history, current medications, and the potential for greater average weight loss compared to other weight loss medications
However, the potential of these drugs in assisting with weight loss has caught the attention of patients as well as companies: many of the drugs approved only for diabetes are also prescribed off-label for weight loss
*FREE* shipping on qualifying offers
US$ 23.80
US$ 29.84
US$ 24.56
US$ 24.32
US$ 26.66
US$ 22.97
US$ 27.57
US$ 28.46
US$ 23.66
